DK0543659T3 - Malatoninderivater og kombinationer med antiøstrogene forbindelser til behandling af brystcarcinom hos pattedyr - Google Patents

Malatoninderivater og kombinationer med antiøstrogene forbindelser til behandling af brystcarcinom hos pattedyr

Info

Publication number
DK0543659T3
DK0543659T3 DK92310615.7T DK92310615T DK0543659T3 DK 0543659 T3 DK0543659 T3 DK 0543659T3 DK 92310615 T DK92310615 T DK 92310615T DK 0543659 T3 DK0543659 T3 DK 0543659T3
Authority
DK
Denmark
Prior art keywords
derivatives
breast carcinoma
malatonin
combinations
treatment
Prior art date
Application number
DK92310615.7T
Other languages
Danish (da)
English (en)
Inventor
Michael Edward Flaugh
James Allen Clemens
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0543659T3 publication Critical patent/DK0543659T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK92310615.7T 1991-11-21 1992-11-20 Malatoninderivater og kombinationer med antiøstrogene forbindelser til behandling af brystcarcinom hos pattedyr DK0543659T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/796,108 US5196435A (en) 1991-11-21 1991-11-21 Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma

Publications (1)

Publication Number Publication Date
DK0543659T3 true DK0543659T3 (da) 1995-07-17

Family

ID=25167321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92310615.7T DK0543659T3 (da) 1991-11-21 1992-11-20 Malatoninderivater og kombinationer med antiøstrogene forbindelser til behandling af brystcarcinom hos pattedyr

Country Status (8)

Country Link
US (1) US5196435A (fr)
EP (1) EP0543659B1 (fr)
JP (1) JPH05221861A (fr)
AT (1) ATE122232T1 (fr)
CA (1) CA2083359A1 (fr)
DE (1) DE69202441T2 (fr)
DK (1) DK0543659T3 (fr)
ES (1) ES2072102T3 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US5441563A (en) * 1993-07-06 1995-08-15 Armstrong World Industries, Inc. Highly insoluble azole embossing inhibitor and the use thereof
US6180657B1 (en) 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
AU2310895A (en) * 1994-04-07 1995-10-30 Cemaf Novel spiro{indole-pyrrolidine} derivatives as melatoninergic agonists, method for preparing same and use thereofas a drug
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
EP0748627A3 (fr) * 1995-06-14 1997-05-21 Lilly Co Eli Agonistes de la mélatonine pour l'utilisation dans le traitement d'hyperplasies prostatiques bénignes
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
FR2787447B1 (fr) * 1998-12-18 2001-03-23 Centre Nat Rech Scient Nouveaux derives de melatonine et medicament comprenant de tels derives
PT1175433E (pt) 1999-05-04 2005-11-30 Strakan Int Ltd Glicosidos androgenos e sua actividade androgenica
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
US6638966B2 (en) * 2000-09-19 2003-10-28 University Of Iowa Research Foundation Use of melatonin analogues for induction of general anesthesia
US6552064B2 (en) * 2000-09-19 2003-04-22 University Of Iowa Research Foundation Use of melatonin for induction of general anesthesia
US7062312B2 (en) * 2001-01-17 2006-06-13 Pediamed Pharmaceuticals, Inc. Combination and method including a visual marker for determining compliance with a medication regimen
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
WO2005062992A2 (fr) * 2003-12-23 2005-07-14 Abraxis Bioscience, Inc Derives substitues de melatonine, procede de fabrication et methodes d'utilisation
KR101505884B1 (ko) * 2006-05-22 2015-03-25 호르모스 메디칼 리미티드 만성 비세균성 전립선염 치료용 선택적 에스트로겐 수용체 조절제 또는 아로마타아제 저해제
WO2008099060A2 (fr) * 2007-02-14 2008-08-21 Hormos Medical Ltd Procédés de préparation de fispémifène à partir d'ospémifène
CN101636372B (zh) * 2007-02-14 2013-03-27 霍尔莫斯医疗有限公司 有治疗价值的三苯基丁烯衍生物的制备方法
WO2014060639A1 (fr) 2012-10-19 2014-04-24 Fermion Oy Procédé pour la préparation d'ospémifène
KR101861081B1 (ko) * 2015-08-05 2018-05-28 인제대학교 산학협력단 멜라토닌 유도체를 포함하는 염증성 질환, 알러지 질환 또는 암 질환 예방 또는 치료용 조성물
CN114680114B (zh) * 2022-04-27 2022-11-15 华中农业大学 褪黑素衍生物在防治植物真菌病害中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
EP0002097B1 (fr) * 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Dérivés de triphénylalcène, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4543360A (en) * 1981-09-10 1985-09-24 Degussa Aktiengesellschaft 2-(Hydroxy-phenyl)-indoles and process for their production
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
CA1299174C (fr) * 1987-02-02 1992-04-21 Michael Edward Flaugh Alkylmelatonines
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
ATE122232T1 (de) 1995-05-15
DE69202441T2 (de) 1995-10-26
DE69202441D1 (de) 1995-06-14
CA2083359A1 (fr) 1993-05-22
ES2072102T3 (es) 1995-07-01
JPH05221861A (ja) 1993-08-31
US5196435A (en) 1993-03-23
EP0543659B1 (fr) 1995-05-10
EP0543659A1 (fr) 1993-05-26

Similar Documents

Publication Publication Date Title
DK0543659T3 (da) Malatoninderivater og kombinationer med antiøstrogene forbindelser til behandling af brystcarcinom hos pattedyr
SE8503680D0 (sv) Indolderivat
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
DE69106237T2 (de) Antimigräne Alkoxypyrimidinderivate.
NO931058D0 (no) Fremgangsmaate for fremstilling av formoterol og beslektede forbindelser
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
ES549873A0 (es) 1,4-dihidropiridin-carboxiamidas.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK627289D0 (da) Anvendelse af bicyclononanderivater
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE3777665D1 (de) Heptanoyl-glu-asp-ala-amino-saeure-immunstimulanten.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DK0378146T3 (da) Polyamin-derivater som antineoplastiske midler
NO990436D0 (no) FremgangsmÕte for behandling av bipolar forstyrrelse
IL89901A0 (en) Strobilurine derivatives
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK435089A (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
FI890173A (fi) Isoxazoler med nootropisk verkan.
DK237688A (da) Fremgangsmaade til vaadbehandling af kvalitetsgarner
SE9000324D0 (sv) Foerfarande foer vaermebehandling
IT9022309A0 (it) Composizione terapeutica per il trattamento della vitiligine
IT8220082A0 (it) Composizione atta al trattamento terapeutico dei tumori.
IT1191617B (it) Propionilanilidi farmacologicamente attive